Table 5.
Cost, outcomes, and cost-effectiveness from lifetime Markov model
| Strategy | Experimental Intervention | Standard Care | Difference |
|---|---|---|---|
| Cost (2010 U.S. $) | |||
| Cost of cessation treatment in trial | 189 | 37 | 152 |
| Discounted cost of follow-up health services | 183,868 | 183,977 | −109 |
| Total discounted cost | 184,057 | 184,014 | 43 |
| Outcomes | |||
| Discounted Life Years | 23.766 | 23.627 | 0.139 |
| Discounted Quality Adjusted Life Years | 15.233 | 15.122 | 0.101 |
| Incremental Cost-Effectiveness Ratio (ICER) | |||
| $/LY | 312 | ||
| $/QALY | 428 | ||